annual total liabilities:
$1.33B-$559.10M(-29.58%)Summary
- As of today (September 13, 2025), BMRN annual total liabilities is $1.33 billion, with the most recent change of -$559.10 million (-29.58%) on December 31, 2024.
- During the last 3 years, BMRN annual total liabilities has fallen by -$401.63 million (-23.18%).
- BMRN annual total liabilities is now -29.58% below its all-time high of $1.89 billion, reached on December 31, 2023.
Performance
BMRN Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$1.43B+$75.68M(+5.59%)Summary
- As of today (September 13, 2025), BMRN quarterly total liabilities is $1.43 billion, with the most recent change of +$75.68 million (+5.59%) on June 30, 2025.
- Over the past year, BMRN quarterly total liabilities has dropped by -$351.59 million (-19.74%).
- BMRN quarterly total liabilities is now -32.08% below its all-time high of $2.10 billion, reached on September 30, 2020.
Performance
BMRN quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BMRN Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.6% | -19.7% |
| 3 y3 years | -23.2% | -12.9% |
| 5 y5 years | -15.1% | -30.8% |
BMRN Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.6% | at low | -24.4% | +7.4% |
| 5 y | 5-year | -29.6% | at low | -32.1% | +7.4% |
| alltime | all time | -29.6% | >+9999.0% | -32.1% | >+9999.0% |
BMRN Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.43B(+5.6%) |
| Mar 2025 | - | $1.35B(+1.7%) |
| Dec 2024 | $1.33B(-29.6%) | $1.33B(-7.4%) |
| Sep 2024 | - | $1.44B(-19.3%) |
| Jun 2024 | - | $1.78B(-1.0%) |
| Mar 2024 | - | $1.80B(-4.8%) |
| Dec 2023 | $1.89B(+6.7%) | $1.89B(+1.5%) |
| Sep 2023 | - | $1.86B(+4.5%) |
| Jun 2023 | - | $1.78B(+0.3%) |
| Mar 2023 | - | $1.77B(+0.2%) |
| Dec 2022 | $1.77B(+2.3%) | $1.77B(+4.5%) |
| Sep 2022 | - | $1.70B(+3.3%) |
| Jun 2022 | - | $1.64B(-1.8%) |
| Mar 2022 | - | $1.67B(-3.5%) |
| Dec 2021 | $1.73B(-0.5%) | $1.73B(+1.2%) |
| Sep 2021 | - | $1.71B(+3.3%) |
| Jun 2021 | - | $1.66B(+0.8%) |
| Mar 2021 | - | $1.64B(-5.7%) |
| Dec 2020 | $1.74B(+11.1%) | $1.74B(-17.2%) |
| Sep 2020 | - | $2.10B(+1.9%) |
| Jun 2020 | - | $2.07B(+39.3%) |
| Mar 2020 | - | $1.48B(-5.4%) |
| Dec 2019 | $1.57B(+3.1%) | $1.57B(+5.7%) |
| Sep 2019 | - | $1.48B(+3.6%) |
| Jun 2019 | - | $1.43B(-4.4%) |
| Mar 2019 | - | $1.50B(-1.5%) |
| Dec 2018 | $1.52B(-18.6%) | $1.52B(-14.6%) |
| Sep 2018 | - | $1.78B(+2.3%) |
| Jun 2018 | - | $1.74B(-2.8%) |
| Mar 2018 | - | $1.79B(-4.2%) |
| Dec 2017 | $1.87B(+48.6%) | $1.87B(+5.8%) |
| Sep 2017 | - | $1.77B(+44.3%) |
| Jun 2017 | - | $1.22B(+4.7%) |
| Mar 2017 | - | $1.17B(-7.0%) |
| Dec 2016 | $1.26B(-5.4%) | $1.26B(+5.1%) |
| Sep 2016 | - | $1.20B(+2.3%) |
| Jun 2016 | - | $1.17B(-15.0%) |
| Mar 2016 | - | $1.38B(+3.6%) |
| Dec 2015 | $1.33B(+38.0%) | $1.33B(-0.3%) |
| Sep 2015 | - | $1.33B(+3.1%) |
| Jun 2015 | - | $1.29B(+4.7%) |
| Mar 2015 | - | $1.23B(+28.1%) |
| Dec 2014 | $962.56M(+6.0%) | $962.56M(+3.3%) |
| Sep 2014 | - | $931.99M(+5.5%) |
| Jun 2014 | - | $883.72M(+0.4%) |
| Mar 2014 | - | $880.61M(-3.0%) |
| Dec 2013 | $908.18M(+55.0%) | $908.18M(+164.0%) |
| Sep 2013 | - | $344.04M(+0.2%) |
| Jun 2013 | - | $343.26M(-1.4%) |
| Mar 2013 | - | $348.14M(-40.6%) |
| Dec 2012 | $585.88M(+10.4%) | $585.88M(+6.1%) |
| Sep 2012 | - | $552.18M(+3.8%) |
| Jun 2012 | - | $532.10M(+1.3%) |
| Mar 2012 | - | $525.13M(-1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $530.63M(+71.5%) | $530.63M(+1.9%) |
| Sep 2011 | - | $520.54M(+62.8%) |
| Jun 2011 | - | $319.69M(+2.7%) |
| Mar 2011 | - | $311.36M(+0.6%) |
| Dec 2010 | $309.35M(-48.0%) | $309.35M(-53.0%) |
| Sep 2010 | - | $658.87M(+5.8%) |
| Jun 2010 | - | $622.55M(+0.3%) |
| Mar 2010 | - | $620.97M(+4.4%) |
| Dec 2009 | $594.98M(-5.6%) | $594.98M(+5.2%) |
| Sep 2009 | - | $565.50M(+0.8%) |
| Jun 2009 | - | $561.00M(-10.4%) |
| Mar 2009 | - | $626.34M(-0.6%) |
| Dec 2008 | $630.02M(+0.4%) | $630.02M(+1.4%) |
| Sep 2008 | - | $621.14M(-1.2%) |
| Jun 2008 | - | $628.53M(+1.6%) |
| Mar 2008 | - | $618.54M(-1.4%) |
| Dec 2007 | $627.55M(+81.6%) | $627.55M(+1.8%) |
| Sep 2007 | - | $616.51M(+0.4%) |
| Jun 2007 | - | $614.04M(+115.4%) |
| Mar 2007 | - | $285.05M(-17.5%) |
| Dec 2006 | $345.63M(+26.7%) | $345.63M(+0.2%) |
| Sep 2006 | - | $344.95M(-17.8%) |
| Jun 2006 | - | $419.83M(-5.1%) |
| Mar 2006 | - | $442.22M(+62.1%) |
| Dec 2005 | $272.76M(-9.4%) | $272.76M(-0.5%) |
| Sep 2005 | - | $274.22M(-1.2%) |
| Jun 2005 | - | $277.69M(+2.4%) |
| Mar 2005 | - | $271.17M(-9.9%) |
| Dec 2004 | $300.94M(+117.3%) | $300.94M(+1.0%) |
| Sep 2004 | - | $298.07M(-2.0%) |
| Jun 2004 | - | $304.23M(+116.5%) |
| Mar 2004 | - | $140.52M(+1.5%) |
| Dec 2003 | $138.49M(+1047.1%) | $138.49M(-2.8%) |
| Sep 2003 | - | $142.48M(-1.0%) |
| Jun 2003 | - | $143.95M(+736.2%) |
| Mar 2003 | - | $17.21M(+42.6%) |
| Dec 2002 | $12.07M(-1.5%) | $12.07M(+7.2%) |
| Sep 2002 | - | $11.26M(+0.6%) |
| Jun 2002 | - | $11.19M(-13.5%) |
| Mar 2002 | - | $12.94M(+5.5%) |
| Dec 2001 | $12.26M(+76.7%) | $12.26M(+96.6%) |
| Sep 2001 | - | $6.24M(+17.2%) |
| Jun 2001 | - | $5.32M(+44.4%) |
| Mar 2001 | - | $3.68M(-46.9%) |
| Dec 2000 | $6.94M(+34.2%) | $6.94M(+89.0%) |
| Sep 2000 | - | $3.67M(+26.9%) |
| Jun 2000 | - | $2.89M(-39.2%) |
| Mar 2000 | - | $4.76M(-8.0%) |
| Dec 1999 | $5.17M(+144.6%) | $5.17M(+144.7%) |
| Sep 1999 | - | $2.11M(-93.8%) |
| Jun 1999 | - | $33.99M(+1862.0%) |
| Mar 1999 | - | $1.73M(-18.1%) |
| Dec 1998 | $2.11M(+676.0%) | - |
| Dec 1998 | - | $2.11M |
| Dec 1997 | $272.50K | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual total liabilities?
- What is the all time high annual total liabilities for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual total liabilities year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly total liabilities year-on-year change?
What is BioMarin Pharmaceutical Inc. annual total liabilities?
The current annual total liabilities of BMRN is $1.33B
What is the all time high annual total liabilities for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual total liabilities is $1.89B
What is BioMarin Pharmaceutical Inc. annual total liabilities year-on-year change?
Over the past year, BMRN annual total liabilities has changed by -$559.10M (-29.58%)
What is BioMarin Pharmaceutical Inc. quarterly total liabilities?
The current quarterly total liabilities of BMRN is $1.43B
What is the all time high quarterly total liabilities for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly total liabilities is $2.10B
What is BioMarin Pharmaceutical Inc. quarterly total liabilities year-on-year change?
Over the past year, BMRN quarterly total liabilities has changed by -$351.59M (-19.74%)